Information
Learning Objective 1
A review of new or repurposed medications used in unique genetic epilepsy syndromes, from dosing to interactions, monitoring parameters as well as side effects
Learning Objective 2
Discuss medication considerations for patients treated with the ketogenic diet - a discussion on common carbohydrate blunders, alkalizing agents, stooling supplements, and ASMs that affect diet
Learning Objective 3
Demonstrate the array of considerations for women (sex assigned at birth), such as interactions with contraceptives, pregnancy considerations, and even bone density issues
Target Audience
CliniciansFellows/TraineesAdvanced Practice Providers (APPs)AdvocatesNursesPharmacists
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Demographics
ClinicalYoung ProfessionalsFirst-time Attendee
Session Content Includes
and Inclusion (DEI)DiversityEquityPediatric
Education Credits
1.5 CME1.5 CNE1.5 CPE
Session ID
APPSIG26
Presentation Id
3452227
Event ID
24056
Session Type
Session

